January 14, 2012 
I just got added to the agenda for the February PCMA event so look me up if you’ll be there. I’ve spoken on the topic of copay cards a few times for AIS in the past. Since then, there have been a few significant events:
- The Pfizer Lipitor strategy and push around a copay card.
- The PCMA study on the impact of copay cards.
- CVS Caremark’s changes to their formulary of which some were attributed to the existence of copay cards.
As always, I welcome comments, articles, suggestions, or data to support this discussion. It is certainly one where there is limited data or facts. Thanks.
Enabling Healthy Decisions 
No comments yet... Be the first to leave a reply!